-
Genmab Announces the Closing of Over-Allotment Option in Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase
-
Genmab Announces the Closing of Over-Allotment Option in Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase
-
Genmab Announces the Completion of its Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase
-
Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering
-
Genmab (GMAB) IPO Opens Modesty Higher
-
Genmab A/S (GEN) Prices 28.5M ADS IPO at $17.75/ADS
-
Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States
-
Genmab Commences Public Offering of American Depositary Shares (ADSs) in the United States
-
UPDATE: Genmab A/S (GMAB) Files U.S. IPO

